Clinical Trial Update: GOS to Reduce Symptom Severity in IBS [NA]

View source ↗

Summary

A completed clinical trial sponsored by Clasado evaluated galacto-oligosaccharide (GOS) for reducing symptom severity in irritable bowel syndrome, including con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Irritable Bowel Syndrome Mixed
• Irritable Bowel Syndrome with Constipation
• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Bimuno GOS (galacto-oligosaccharide)

Snippet

Sponsor: Clasado | Conditions: Irritable Bowel Syndrome, Irritable Bowel Syndrome - Constipation | NA | Status: COMPLETED